“…This approach can be obtained i) pharmacologically with α7nAChR agonists such as nicotine (Cui & Li, 2010), GTS21 (Kox et al, 2011), and AR-R17779 (van Westerloo et al, 2006), activation of the central cholinergic pathway with an AChesterase inhibitor (galantamine) (Pavlov et al, 2009) or CNI-1492, a cytokine inhibitor and synthetic guanylhydrazone mitogenactivated protein kinase blocker (Tracey, 1998), ii) high fat enteral feeding inducing the release of CCK that activates CCK1 vagal afferents thus activating the CAP (Luyer et al, 2005), iii) complementary and alternative medicines such as meditation, yoga, acupuncture, hypnosis, known to activate the VN (Keefer et al, 2013), iv) physical exercise (Mora et al, 2007), v) VNS which appears as the most interesting tool because already validated in drug resistant epilepsy and depression in human with very few side effects (Bonaz et al, 2013).…”